Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: Design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins

Archives of Virology

Volumn 144, Issue 12, 1999, Pages 2313-2330

  Falconar, A K I ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANTIGEN DETECTION; DENGUE VIRUS MEMBRANE PROTEIN; DENGUE VIRUS; EPITOPE; MONOCLONAL ANTIBODY; SEROTYPE; SYNTHETIC PEPTIDE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CROSS REACTIONS; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; IMMUNIZATION, PASSIVE; IMMUNOBLOTTING; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN PRECURSORS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033394257     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050646     Document Type: Article

References (37)

1. 1. Aaskov JG, Geysen HM, Mason TJ (1989) Serologically defined linear epitopes in the envelope protein of dengue-2 (Jamaica strain 1409). Arch Virol 105: 209-221
2. 2. Allison AC (1998) The mode of action of immunological adjuvants. Dev Biol Standards 92: 3-11
3. 3. Bray M, Lai CJ (1991) Dengue virus premembrane and membrane proteins elicit a protective immune response. Virology 185: 505-508
4. 4. Chu MC, Huang GH, Roehrig JT (1992) Mapping the epitopes of dengue envelope glycoprotein that mediate virus neutralisation and enhancement. Am J Trop Med Hyg 47: 164-165
5. 5. Falconar AKI (1997) The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142: 897-916
6. 6. Falconar AKI, Young PR (1990) Immunoaffinity purification of the native dimer forms of the flavivirus nonstructural protein, NS1. J Virol Methods 30: 323-332
7. 7. Falconar AKI, Young PR, Miles MA (1994) Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein. Arch Virol 137: 315-326
8. 8. Falconar AKI, Young PR (1991) Production of dimer-specific and dengue group cross-reactive mouse monoclonal antibodies to the dengue-2 nonstructural glycoprotein, NS1. J Gen Virol 72: 961-965
9. 9. Geysen HM, Mason TL, Rodda SJ (1988) Cognitive features of continuous antigenic determinants. J Mol Recogn 1: 32-41
10. 10. Gould EA, Clegg JCS (1986) Growth, titration and purification of togaviruses. In: Mahy BVJ (ed) Virology: a practical approach. Oxford University Press, Oxford, pp 43-88
11. 11. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-496
12. 12. Hanin V, Dery O, Boquet D, Sagot M-A, Creminon C, Couraud JV, Grassi J (1998) Importance of hydropathic complementarity for the binding of neuropeptide substance P to a monoclonal antibody: equilibrium and kinetic studies. Mol Immunol 34: 829-838
13. 13. Heinz FX, Auer G, Stiasny K, Holzmann, Mandl C, Guirakhoo F, Kunz C (1994) The interaction of the flavivirus envelope proteins: implications for virus entry and release. Arch Virol [Suppl] 9: 339-348
14. 14. Henchal EA, McCown JM, Burke DS, Seguin MC, Brandt WE (1985) Epitope analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg 34: 162-169
15. 15. Hopp TP, Woods KR (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 78: 3824
16. 16. Innis BL, Thirawuth V, Hemachudha C (1989) Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus. Am J Trop Med Hyg 40: 676-687
17. 17. Karagouni EE, Hadjiipetrou-Kourounakis L (1990) Regulation of isotype immunoglobulin production by adjuvants in vivo. Scand J Immunol 31: 745-754
18. 18. Kaufman BM, Summers PL, Dubois DR, Eckels KH (1987) Monoclonal antibodies against the dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 36: 427-434
19. 19. Kaufman BM, Summers PL, Dubois DR, Houston Cohen W, Gentry MK, Timchak RL, Burke DS, Eckels KH (1989) Monoclonal antibodies for the dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 41: 576-580
20. 20. Lee E, Weir RC, Dalgarno L (1997) Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology 232: 281-290
21. 21. Mason PW, Zugel MU, Semproni AR, Fornier MJ, Mason TL (1990) The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli. J Gen Virol 71: 2107-2114
22. 22. Megret F, Hugnot JP, Falconar AKI, Gentry MK, Morens DM, Murray JM, Schlesinger JJ, Wright PJ, Young PR, Van Regenmortel MHV, Deubel V (1992) Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope protein. Virology 187: 408-491
23. 23. Meisel H, Sominskaya I, Pumpens P, Pushko P, Borisova G, Deepen R, Lu X, Spiller GH, Kruger DH, Grens E (1994) Fine mapping and functional characterisation of two immunodominant regions from the preS2 sequence of hepatitis B virus. Intervirology 37: 330-339
24. 24. Murray JM, Aaskov JG, Wright PJ (1993) Processing of the dengue virus type 2 proteins prM and C-prM. J Gen Virol 74: 175-182
25. 25. Petersen G, Song D, Hugle-Dorr B, Oldenburg I, Bautz EK (1995) Mapping of linear epitope recognised by monoclonal antibodies with gene-fragment phage display libraries. Mol Gen Genet 249: 425-431
26. 26. Randolph VB, Winkler G, Stollar V (1990) Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology 174: 450-458
27. 27. Relf WA, Cooper J, Brandt ER, Hayman WA, Anders RF, Pruksakorn S, Currie B, Saul A, Good MF (1996) Mapping a conserved conformational epitope from the M protein of group A streptococci. Peptide Res 9: 12-20
28. 28. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375: 291-298
29. 29. Roehrig JT, Bolin RA, Kelly RG (1998) Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246: 317-328
30. 30. Roehrig JT, Johnson AJ, Hunt AR, Beaty BJ, Mathews JM (1990) Antibodies to the dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 177: 668-675
31. 31. Rose GD (1978) Prediction of chain turns in globular proteins on a hydrophobic basis. Nature 272: 586-590
32. 32. Schlesinger JJ, Foltzer M, Chapman S (1993) The Fc portion of antibody to yellow fever virus NS1 is dependent of protection against YF encephalitis in mice. Virology 192: 132-141
33. 33. Simmons M, Porter KR, Escamilla J, Graham R, Watts DM, Eckels KH, Hayes CG (1998) Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies. Am J Trop Med Hyg 58: 144-151
34. 34. Van Regenmortel MHV, Muller S (1998) D-peptides as immunogens and diagnostic reagents. Curr Opin Biotechnol 9: 377-382
35. 35. Van Regenmortel MHV, Guichard G, Benkirane N, Briand JP, Muller S, Brown F (1998) The potential of retro-inverso peptides as synthetic vaccines. Dev Biol Standards 92: 139-143
36. 36. Vihinen M, Torkkila E, Riikonen P (1994) Accuracy of protein flexibility predictions. Proteins 19: 141-149
37. 37. Williams RC, Malone CC, Kolaskar AS, Kulkarni-Kale U (1997) Antigenic determinants reacting with rheumatoid factor: epitopes with different primary sequences share similar conformation. Mol Immunol 34: 543-556